Evidence map›Paper›PMID 41683810›Full record

ReviewInternational journal of molecular sciences2026

Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review.

Klairi Papachristou, Maria Angelara, Konstantinos Manganas, Theodoros Androutsakos

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Klairi PapachristouDepartment of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Maria AngelaraDepartment of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Konstantinos ManganasFirst Department of Propaedeutic and Internal Medicine, "Laiko" Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0002-9844-2813
Theodoros AndroutsakosDepartment of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.ORCID 0000-0003-2556-6230

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary biliary cholangitis (PBC) is a chronic, cholestatic disease, with a female predominance and a female-to-male ratio of approximately 10:1, that typically follows a slowly progressive, decades-long disease course. The disease is usually asymptomatic at the time of diagnosis and it is not uncommon for a patient to present with cirrhosis. Patients with PBC may also present with extrahepatic manifestations, including pruritus, chronic fatigue, and osteoporosis, while co-existence of other autoimmune diseases, such as autoimmune hepatitis, Hashimoto's disease, Sjogren's syndrome, or systemic sclerosis is not uncommon. The exact pathogenesis of PBC remains elusive with a variety of different factors, including genetic, epigenetic, and environmental ones, alongside immune dysregulation leading to a dysfunction of biliary "bicarbonate umbrella", a protective mechanism by which cholangiocyte-secreted bicarbonate creates an alkaline microenvironment shielding the epithelium from bile acid-induced injury, and increased biliary epithelial cells apoptosis.

Indexed as

Liver Cirrhosis, BiliaryAnimalsHumansautoimmune liver diseasebicarbonate umbrellabile acidsgenetic factorsimmune dysregulationlivermiRNAspathogenesisprimary biliary cholangitis

Identifiers

PMID41683810
PMCPMC12897627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.